Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lucia Morago"'
Autor:
Milagros Muñoz-Chimeno, Silvia Bartúren, Maira Alejandra García-Lugo, Lucia Morago, Álvaro Rodríguez, Juan Carlos Galán, Alfredo Pérez-Rivilla, Mercedes Rodríguez, Rosario Millán, Manuel del Álamo, Roberto Alonso, Laura Molina, Aitziber Aguinaga, Ana Avellón
Publikováno v:
Eurosurveillance. 27
Background Hepatitis E virus genotype 3 (HEV-3) is widely distributed throughout Europe, with incidence of infections increasing in many countries. Belgium, Bulgaria, France, Germany, Italy, the Netherlands and the United Kingdom have reported the di
Autor:
Milagros Muñoz-Chimeno, Nazaret Díaz-Sánchez, Lucía Morago, Vanessa Rodríguez-Paredes, Silvia Barturen, Álvaro Rodríguez-Recio, Maira Alejandra García-Lugo, Maria Isabel Zamora, María Mateo, Mónica Sánchez-Martínez, Ana Avellón
Publikováno v:
Microorganisms, Vol 12, Iss 9, p 1875 (2024)
HEV antibody detection constitutes the main screening test for HEV infection. The aim of this study is to compare the sensitivity and specificity of four techniques: LIAISON® MUREX DiaSorin anti-HEV IgG and anti-HEV IgM assays, Hepatitis E VIRCLIA®
Externí odkaz:
https://doaj.org/article/6ebe3d3abc634b16b2e2696d0cd38f2a
Autor:
Milagros Muñoz-Chimeno, Jorge Valencia, Alvaro Rodriguez-Recio, Guillermo Cuevas, Alejandra Garcia-Lugo, Samuel Manzano, Vanessa Rodriguez-Paredes, Beatriz Fernandez, Lucía Morago, Concepción Casado, Ana Avellón, Pablo Ryan
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Point of care rapid diagnostic tests (POC-RDT) for Hepatitis C virus (HCV), Human Immunodeficiency virus (HIV) and Hepatitis B virus (HBV), are ideal for screening in non-clinical outreach settings as they can provide immediate results and f
Externí odkaz:
https://doaj.org/article/911193f7fd264910aa23db6f30af0189
Publikováno v:
Journal of Medical Virology. 87:1934-1939
Hepatitis E virus (HEV) acute infection is often diagnosed only by anti-HEV IgM ELISA methods, whose sensitivity varies, according to different reports. Reports assessing the specificity of commercial assays for anti-HEV IgG testing are scarce, and e